ACR Updates: COVID-19

 

Breaking News

Advice from the American College of Rheumatology: Reopening Strategies During the COVID-19 Pandemic

As COVID-19 stay-at-home orders have been revised and repealed, rheumatology practices have also started to reopen. The degree to which rheumatologists and rheumatology health professionals reduced the number of face-to-face visits and other services has varied. This is entirely appropriate as local circumstances, including regional prevalence of SARS-CoV-2, local capacity for testing and tracking, physical (also known as “social”) distancing, and supplies of personal protective equipment have varied from region to region.

This guidance from the ACR is intended for rheumatologists and rheumatology health professionals to consider as they evaluate local conditions, design reopening procedures, monitor progress, and advise patients during the transition to this new phase of patient care during the COVID-19 pandemic. View Guidance

 

ACR to Host Town Hall on COVID-19 Guidance for Community Practices

The ACR is hosting a virtual town hall for the rheumatology community on Monday, July 13, at 7:00–8:00 PM ET. Hear the latest on utilizing telehealth, strategies for reopening clinics, and tips for handling federal relief funds and reporting. Read more

 

HHS Opens Relief Payment Applications for Medicaid and CHIP Physicians and Organizations

The Department of Health and Human Services (HHS) has launched an application portal to distribute $15 billion in CARES Act Provider Relief Fund payments to eligible Medicaid and CHIP physicians and organizations. The payment will be at least 2 percent of reported gross revenue from patient care, and the final amount will be determined based on submitted data, including the number of Medicaid patients served. Eligible physicians and organizations have until July 20, 2020, to submit their application and report other necessary information, such as annual patient revenue data. Read more

 

See All Breaking News

 

Practice and Advocacy Resources

ACR COVID-19 practice and advocacy resourcesThe ACR’s COVID-19 Practice and Advocacy Task Force continues to work rapidly to provide support to you during this unprecedented time. You’ll find guidance documents that include approaches to drug shortages, support for telehealth, information about federal stimulus relief aid, and guidance for infusions. Working with experts in COVID-related topics, we are focused on developing meaningful information and resources to help guide you.

Practice and Advocacy Resources

COVID-19 Manufacturer Resources and Patient Assistance Programs  - New

 

Clinical Guidance for Pediatric Patients

ACR COVID-19 clinical guidance for pediatric patients with rheumatic diseasesThe ACR has developed two new clinical guidance documents for pediatric patients in the context of the COVID-19 pandemic, including for the care of children with pediatric rheumatic disease, and for the management of inflammatory syndromes in children with recent or concurrent infections with SARS-CoV-2, specifically Multisystem Inflammatory Syndrome in Children (MIS-C). All recommendations are based on current knowledge and will be revised as circumstances and evidence evolve.

 



COVID-19 Clinical Guidance Summary for Pediatric Patients with Rheumatic Disease   New - June 18, 2020

The recommendations for pediatric rheumatology patients address various treatment options and provide general guidance, as well as direction for when to start, stop or reduce medications. Peer reviewed journal publication in progress, will be posted here when available.

Clinical Guidance Summary for Pediatric Patients with MIS-C Associated with SARS-CoV-2 and Hyperinflammation in COVID-19   New - June 18, 2020

The recommendations for MIS-C focus on general guidance, diagnostic evaluation, and therapy options, as well as comparing and contrasting the features of MIS-C and Kawasaki Disease. For hyperinflammation in COVID-19, the recommendations also focus on general guidance, as well as immunomodulatory treatment. Peer reviewed journal publication in progress, will be posted here when available.

You can also access the clinical guidance information on your iOS or Android mobile device. Download the free ACR Guideline and Criteria App on the App Store or Google Play.

 

Clinical Guidance for Adult Patients with Rheumatic Diseases

ACR COVID-19 clinical guidance for patients with rheumatic diseasesThe ACR has developed clinical guidance for the care of adult patients with rheumatic diseases during the COVID-19 pandemic. Populations considered include patients with a documented COVID-19 infection, those who are stable following exposure to SARS-CoV-2 (but without known infection), and patients who are stable with no infection or exposure. The recommendations address various treatment options and provide general guidance, as well as direction for when to start, stop, or reduce medications. All recommendations are based on current knowledge and will be revised as circumstances and evidence evolve.

 

 

COVID-19 Clinical Guidance Summary for Adult Patients with Rheumatic Diseases  - Updated June 5, 2020

ACR Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1  - Published June 5, 2020

How to cite this article: Mikuls TR, Johnson SR, Fraenkel L, Arasaratnam RJ, Baden LR, Bermas BL, et al. American College of Rheumatology guidance for the management of adult patients with rheumatic disease during the COVID-19 pandemic. Arthritis Rheumatol doi: https://onlinelibrary.wiley.com/doi/abs/10.1002/art.41301. E-pub ahead of print.

You can also access the clinical guidance information on your iOS or Android mobile device. Download the free ACR Guideline and Criteria App on the App Store or Google Play.

 

COVID-19 State-of-the-Art Clinical Symposium Recordings

COVID-19 State-of-the-Art Clinical Symposium RecordingsWatch three of our featured COVID-19 sessions recorded during the virtual 2020 State-of-the-Art Clinical Symposium, presented by rheumatology thought leaders Jinoos Yazdany, MD, MPH, and Mehrdad Matlloubian, MD, PhD.

 

COVID-19 Epidemiology, Transmission and Insights from Global Registry Data  

Immunology of COVID-19 and Potential Treatments  

2020 SOTA COVID-19 Panel Q&A with Jinoos Yazdany, MD, MPH, and Mehrdad Matloubian, MD, PhD  

 

Global Rheumatology Alliance

COVID-19 Global Rheumatology AllianceThe COVID-19 Global Rheumatology Alliance, a section of the American College of Rheumatology, is a provider-entered registry aiming to collect data on rheumatology patients with COVID-19 and hopes the information will provide guidance for rheumatology professionals when assessing and treating the infection in patients with rheumatic disease.

The Global Rheumatology Community’s Response to the Worldwide COVID-19 Pandemic  

Help Us Help Patients: Report a COVID-19 Case  

 

COVID-19: The Rheumatologist

COVID-19: Wiley Journal Articles

Mental Health & Well-being Resources

ACR Meetings and Program Updates

 

 

Experiencing COVID-19 related drug shortages, practice issues, or any other problems?
Share your comments and questions with us at COVID@rheumatology.org

Updated July 8, 2020 at 11:00 AM ET

© 2020 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us